Liao, Guochao

Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives

Fang, Y., Liao, G., & Yu, B. (2020) · Acta Pharmaceutica Sinica B

Cancer-related Molecular PathwaysProtein Degradation and Inhibitors

Cited by 106

The development of piperidinones as potent MDM2-P53 protein-protein interaction inhibitors for cancer therapy

Liao, G., Yang, D., Ma, L., Li, W., Hu, L., Zeng, L., Wu, P., Duan, L., & Liu, Z. (2018) · European Journal of Medicinal Chemistry

Cancer-related Molecular PathwaysCancer Mechanisms and Therapy

Cited by 63

Fully Synthetic TF-Based Self-Adjuvanting Vaccine Simultaneously Triggers iNKT Cells and Mincle and Protects Mice against Tumor Development

Yang, D., Li, X., Li, J., Liu, Z., Li, T., Liao, P., Luo, X., Liu, Z., Ming, W., & Liao, G. (2024) · Journal of Medicinal Chemistry

Immunotherapy and Immune ResponsesCarbohydrate Chemistry and Synthesis

Cited by 12